Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573397
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerFudan UniversityNot Yet Recruiting
NCT07573397Not Yet Recruiting
—
A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predictin...Fudan University
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
NCT07573579
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest Hospital NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07573579Not Yet Recruiting
Not Applicable
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest...
NCT07573345
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye UniversityRecruiting
NCT07573345Recruiting
—
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye University
NCT07571993
Rheumatoid Arthritis Remission Screening and Prospective SurveillanceFondazione IRCCS Policlinico San Matteo di PaviaRecruiting
NCT07571993Recruiting
—
Rheumatoid Arthritis Remission Screening and Prospective SurveillanceFondazione IRCCS Policlin...
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07574073
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory Immune-related CytopeniaQi dengNot Yet RecruitingPhase 1
NCT07574073Not Yet Recruiting
Phase 1
CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refrac...Qi deng
NCT07572838
Alter-Ego as an Assistive Robotic Device.Istituti Clinici Scientifici Maugeri SpANot Yet Recruiting
NCT07573683
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive IndividualsFoundation University IslamabadRecruitingNot Applicable
NCT07573683Recruiting
Not Applicable
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary...Foundation University Isl...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07572227
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo ClinicEnrolling By InvitationNot Applicable
NCT07572227Enrolling By Invitation
Not Applicable
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)Mayo Clinic
NCT07572240
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy IndividualsRousselot BVBANot Yet RecruitingNot Applicable
NCT07572240Not Yet Recruiting
Not Applicable
A Randomized, Open-Label, Parallel Proof-of-Concept Study to Assess the Effect o...Rousselot BVBA
NCT07572175
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart AssociationNot Yet RecruitingPhase 2
NCT07572175Not Yet Recruiting
Phase 2
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart Associatio...
NCT07572851
Functional Changes and Fall Risk in Older Adults Participating in a Frailty ProgramUniversity of VigoEnrolling By Invitation
NCT07572851Enrolling By Invitation
—
Functional Changes and Fall Risk in Older Adults Participating in a Frailty Prog...University of Vigo
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573774
"Body, Mind, and Self: ACT With Psychoeducation for Female Students Facing Eating Challenges"Menoufia UniversityCompletedNot Applicable
NCT07573774Completed
Not Applicable
"Body, Mind, and Self: ACT With Psychoeducation for Female Students Facing Eatin...Menoufia University
NCT07573722
Neck Exercises for Improving Pelvic Alignment and Low Back PainYuanpei University of Medical TechnologyCompletedNot Applicable
NCT07573722Completed
Not Applicable
Neck Exercises for Improving Pelvic Alignment and Low Back PainYuanpei University of Med...
NCT07572526
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone HealthNot Yet RecruitingNot Applicable
NCT07572526Not Yet Recruiting
Not Applicable
tDCS: Sleep to Mood in Depression (S2M-D)NYU Langone Health
NCT07573111
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationLaguna Biotherapeutics, Inc.Not Yet RecruitingPhase 1
NCT07573111Not Yet Recruiting
Phase 1
Open-label, Single Ascending Dose Study of QUAIL-100 in Pediatric and Young Adul...Laguna Biotherapeutics, I...
Result Breakdown
Not yet recruiting13 (65%)
Recruiting3 (15%)
Enrolling by invitation2 (10%)
Completed2 (10%)
not_applicable10 (50%)
Not Specified6 (30%)
Phase 12 (10%)
Phase 41 (5%)
Phase 21 (5%)